Skip to main content
All lobbying filings

Artemis Policy Group LLC

Artemis Policy Group LLC filed a Q2 report for National Bleeding Disorder Foundation (FKA National Hemophilia Foundation) on July 18, 2025, reporting $50,000 in lobbying income.

Lobbying for National Bleeding Disorder Foundation (FKA National Hemophilia Foundation) · Nonprofit supporting patients with inheritable bleeding disorders.

As filed: ARTEMIS POLICY GROUP LLC for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION).

All filings by Artemis Policy Group LLC · Everything National Bleeding Disorder Foundation (FKA National Hemophilia Foundation) has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
New York

Official filing document

 Lobbyists on this filing 2
  • JOHANNA GRAY
    Previously held: Intern, Senator Barack Obama
  • LESLIE BRADY
    Previously held: Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6
Medicare/Medicaid

H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid

Health Issues

Blood and plasma safety and awareness Bleeding disorders awareness

Insurance

H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)

Budget/Appropriations

Letter to Secretary Kennedy regarding the reductions in force at the Centers for Disease Control and Preventions Division of Blood Disorders and Public Health Genomics Funding for federal hemophilia programs in FY25 House and Senate Labor-HHS Appropriations bills NIH FY25 appropriations

Pharmacy

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

Medical/Disease Research/Clinical Labs

Hemophilia research, prevention, surveillance and service programs and issues

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem